Montreal, December 16, 2021 – The rollout of emicizumab (Hemlibra) in the provinces and territories served by Canadian Blood Services (CBS) is well underway. Emicizumab...
CLICK HERE to access the November 2021 review of novel treatments in haemophilia and other bleeding disorders by the European Haemophilia Consortium.
November 10, 2021 (Montreal) – The Hemlibra rollout continues in provinces served by Canadian Blood Services (CBS). Since access requests from physicians began to be...
November 3, 2021, Ottawa – Canadian Blood Services (CBS) has announced the results of its Request for Proposals (RFP) to supply recombinant factor VIII and...
October 20, 2021, Montreal – Children 12 years of age and under can now access extended half-life (EHL) factor IX in Quebec for the prophylactic...
October 18, 2021, Ottawa – Canadian Blood Services (CBS) announced in its October 18 Customer Letter that the request form for emicizumab (Hemlibra) is now...
Every two or three years, Canadian Blood Services (CBS) and Héma-Québec put out “Requests for Proposals” (RFP) to companies with recombinant factor VIII and IX...
Montreal, September 13, 2021 – In recent weeks, governments in both Quebec and the rest of Canada have expanded access to Hemlibra to patients with...
September 9, 2021, Montréal – The Canadian Hemophilia Society (CHS) was informed late yesterday by Canadian Blood Services (CBS) that access to Hemlibra (emicizumab) will...
August 20, 2021, Montréal – The Canadian Hemophilia Society – Quebec Chapter (CHSQ) has learned that the Québec Ministère de la Santé et des Services...
August 8, 2021, Montreal – There is still no word on access to Hemlibra from ministries of health in Quebec and the rest of Canada...
Jeremy Hall, who the CHS has watched grow up in its community, will finally see his dream come true: he will compete in the Tokyo...
Hello to all, Following its June 27 AGM, the CHS is pleased to announce the arrival of a new leadership on its Board of Directors....
CLICK HERE to access the CHS 2020 Annual Report and the complete Financial Statements.